Genomic Health Inc. (GHDX) Misses Q1 EPS by 3c
Get Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Product revenues: 244.92M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Product revenues: 244.92M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Genomic Health Inc. (NASDAQ: GHDX) reported Q1 EPS of ($0.01), $0.03 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $48.69 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!